Regenxbio (RGNX) Interest Coverage Ratio (2014 - 2026)
Regenxbio (RGNX) posted quarterly Interest Coverage Ratio of 0.39 for Q4 2025, up 107.4% year-over-year from 0.19 in Q4 2024, and up 109.82% quarter-over-quarter from 3.98 in Q3 2025.
Powered by 
Analysis
Regenxbio (RGNX) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Regenxbio's Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 0.39 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 107.4% year-over-year to 0.39; the TTM figure through Dec 2025 stood at 1.4 (up 100.76% YoY), while the FY2025 annual figure was 0.43, up 37.57% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 0.39, up from 3.98 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 48.25 in Q4 2021, with the low at 47.75 in Q3 2024.
- The 5-year median for Interest Coverage Ratio is 3.59 (2022), against an average of 4.67.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio tumbled 396.91% in 2024, then surged 127.82% in 2025.
- Regenxbio's Interest Coverage Ratio stood at 48.25 in 2021, then sank by 90.96% to 4.36 in 2022, then sank by 309.0% to 9.11 in 2023, then soared by 42.06% to 5.28 in 2024, then surged by 107.4% to 0.39 in 2025.
- Business Quant data shows RGNX's Interest Coverage Ratio at 0.39 in Q4 2025, 3.98 in Q3 2025, and 5.76 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | 3.76 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.76 |
| Dec 31, 2025 | -4.70 |
| Sep 30, 2025 | -3.98 |
| Jun 30, 2025 | -5.76 |
| Mar 31, 2025 | 1.42 |
| Dec 31, 2024 | -5.45 |
| Sep 30, 2024 | -75.70 |
| Jun 30, 2024 | -124.80 |
| Mar 31, 2024 | -32.37 |
| Dec 31, 2023 | -46.88 |
| Sep 30, 2023 | -40.00 |
| Jun 30, 2023 | -65.28 |
| Mar 31, 2023 | -24.01 |
| Dec 31, 2022 | -13.40 |
| Sep 30, 2022 | -11.93 |
| Jun 30, 2022 | -9.12 |
| Mar 31, 2022 | -11.67 |
| Dec 31, 2021 | 48.25 |
| Sep 30, 2021 | -8.55 |
| Jun 30, 2021 | -8.20 |